MPLTHealthcareSmall-Cap
MapLight Therapeutics, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for MapLight Therapeutics, Inc. (MPLT), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are MPLT insiders buying or selling?
MapLight Therapeutics, Inc. insiders reported 4 open-market buys ($109.4M) and 31 sells ($28.7M) across 35 Form 4 filings — a net buying position of $80.7M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jul 20, 2026)
Total Form 4 filings
35
SEC EDGAR
Insider filers
12
Insider buys (4)
$109.4M
Insider sells (31)
$28.7M
Insider sentiment
Net buyingNet insider flow of $80.7M in net buying.
Recent MPLT insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 20, 2026 | Jonathan Gillis | CAO and Interim CFO | Sale | 37.0K | $37.12 | $1.4M |
| Jul 20, 2026 | Anatol Kreitzer | Chief Discovery Officer | Sale | 36.3K | $37.09 | $1.3M |
| Jul 18, 2026 | Christopher A. Kroeger | Chief Executive Officer | Sale | 147.6K | $36.87 | $5.4M |
| Jul 18, 2026 | James Woodruff Lillie | Chief Scientific Officer | Sale | 18.3K | $36.88 | $673.6K |
| Jul 18, 2026 | Kristopher Hanson | General Counsel | Sale | 16.5K | $36.82 | $607.9K |
| Jul 18, 2026 | Erin Pennock Foff | Chief Medical Officer | Sale | 47.2K | $36.78 | $1.7M |
| May 19, 2026 | Christopher A. Kroeger | Chief Executive Officer | Sale | 118.2K | $27.19 | $3.2M |
| May 12, 2026 | Kristopher Hanson | General Counsel | Sale | 13.9K | $30.13 | $419.3K |
| May 12, 2026 | Christopher A. Kroeger | Chief Executive Officer | Sale | 68.5K | $28.47 | $1.9M |
| May 12, 2026 | Erin Pennock Foff | Chief Medical Officer | Sale | 4.4K | $28.54 | $126.6K |
| May 12, 2026 | James Woodruff Lillie | Chief Scientific Officer | Sale | 721 | $28.28 | $20.4K |
| May 7, 2026 | Vishwas Setia | Chief Financial Officer | Sale | 36.4K | $28.17 | $1.0M |
| May 7, 2026 | Erin Pennock Foff | Chief Medical Officer | Sale | 50.3K | $28.39 | $1.4M |
| May 7, 2026 | James Woodruff Lillie | Chief Scientific Officer | Sale | 51.7K | $28.40 | $1.5M |
| May 7, 2026 | Kristopher Hanson | General Counsel | Sale | 13.9K | $27.89 | $388.2K |
| May 7, 2026 | Christopher A. Kroeger | Chief Executive Officer | Sale | 49.7K | $28.39 | $1.4M |
| Apr 29, 2026 | Jonathan Gillis | CAAO and PAO | Sale | 69.8K | $29.89 | $2.1M |
| Apr 29, 2026 | Anatol Kreitzer | Chief Discovery Officer | Sale | 45.4K | $29.66 | $1.3M |
| Apr 17, 2026 | Anatol Kreitzer | Chief Discovery Officer | Sale | 3.3K | $26.61 | $88.2K |
| Apr 17, 2026 | Jonathan Gillis | CAAO and PAO | Sale | 3.6K | $26.61 | $95.5K |
| Apr 17, 2026 | Kristopher Hanson | General Counsel | Sale | 1.8K | $26.89 | $49.1K |
| Apr 17, 2026 | Vishwas Setia | Chief Financial Officer | Sale | 2.9K | $26.89 | $78.6K |
| Apr 17, 2026 | James Woodruff Lillie | Chief Scientific Officer | Sale | 4.5K | $27.16 | $122.6K |
| Apr 17, 2026 | Erin Pennock Foff | Chief Medical Officer | Sale | 3.2K | $27.03 | $86.9K |
| Apr 17, 2026 | Christopher A. Kroeger | Chief Executive Officer | Sale | 19.2K | $27.16 | $521.1K |
Showing the 25 most recent of 35 Form 4 filings for MapLight Therapeutics, Inc..
Most active MPLT insiders
- Robert C. Malenka6 filings
- Christopher A. Kroeger5 filings
- Erin Pennock Foff4 filings
- James Woodruff Lillie4 filings
- Kristopher Hanson4 filings
Ask anything about MPLT insider activity
Use Trabud's AI agent to query MapLight Therapeutics, Inc.'s Form 4 history in plain English — "Show me MPLT CEO purchases this year" or compare it against any other ticker.
Open the AI agentMPLT insider trading FAQ
Are MapLight Therapeutics, Inc. insiders buying or selling?
Across 35 SEC Form 4 filings, MapLight Therapeutics, Inc. (MPLT) insiders reported 4 open-market purchases totaling $109.4M and 31 sales totaling $28.7M. That is a net buying position of $80.7M.
How many insiders trade MPLT stock?
12 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for MapLight Therapeutics, Inc.. The most recent filing was accepted on Jul 20, 2026.
Where does Trabud get MPLT insider trading data?
All MPLT insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.